AU2002356319A1 - Dna minor groove binding compounds - Google Patents

Dna minor groove binding compounds

Info

Publication number
AU2002356319A1
AU2002356319A1 AU2002356319A AU2002356319A AU2002356319A1 AU 2002356319 A1 AU2002356319 A1 AU 2002356319A1 AU 2002356319 A AU2002356319 A AU 2002356319A AU 2002356319 A AU2002356319 A AU 2002356319A AU 2002356319 A1 AU2002356319 A1 AU 2002356319A1
Authority
AU
Australia
Prior art keywords
minor groove
binding compounds
groove binding
dna minor
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002356319A
Other languages
English (en)
Inventor
Abedawn Khalaf
Colin Suckling
Roger Waigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Publication of AU2002356319A1 publication Critical patent/AU2002356319A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU2002356319A 2001-12-24 2002-12-24 Dna minor groove binding compounds Abandoned AU2002356319A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0130868.3 2001-12-24
GBGB0130868.3A GB0130868D0 (en) 2001-12-24 2001-12-24 New compounds
PCT/GB2002/005916 WO2003059881A2 (fr) 2001-12-24 2002-12-24 Composés lies au petit sillon de l'adn

Publications (1)

Publication Number Publication Date
AU2002356319A1 true AU2002356319A1 (en) 2003-07-30

Family

ID=9928344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002356319A Abandoned AU2002356319A1 (en) 2001-12-24 2002-12-24 Dna minor groove binding compounds

Country Status (10)

Country Link
US (1) US7700765B2 (fr)
EP (1) EP1467969B1 (fr)
JP (2) JP4624675B2 (fr)
KR (1) KR100966520B1 (fr)
AT (1) ATE509911T1 (fr)
AU (1) AU2002356319A1 (fr)
CA (1) CA2470515C (fr)
ES (1) ES2395273T3 (fr)
GB (1) GB0130868D0 (fr)
WO (1) WO2003059881A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494571C (fr) 2003-12-02 2010-02-09 F.Hoffmann-La Roche Ag Oligonucleotides renfermant des tiges moleculaires
US20080176220A1 (en) * 2004-02-26 2008-07-24 Thomsen Bioscience Method, Kit and System for Enhanced Nested Pcr
GB0412468D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
NZ565470A (en) * 2005-07-29 2010-11-26 4Sc Ag Novel heterocyclic NF-kB inhibitors
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
US9650421B2 (en) 2011-09-02 2017-05-16 Northwestern University Self-assembled nanostructures
CN104845967B (zh) 2015-04-15 2020-12-11 苏州新海生物科技股份有限公司 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用
WO2018047148A1 (fr) 2016-09-12 2018-03-15 Novartis Ag Composés pour inhibition du miarn
US11124479B2 (en) * 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1308516C (fr) * 1987-07-06 1992-10-06 J. William Lown Agents antiviraux et anticancereux oligopeptidiques
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
US5273991A (en) 1992-07-29 1993-12-28 Research Corporation Technologies, Inc. Imidazole-containing compositions and methods of use thereof analogs of distamycin
US5698674A (en) 1994-04-13 1997-12-16 The Regents Of The University Of California Triheterocyclic peptides capable of binding the minor and major grooves of DNA
GB9416005D0 (en) 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
JP2000503999A (ja) * 1996-02-02 2000-04-04 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー ジスタマイシン誘導体、その調製方法、および抗腫瘍および抗ウイルス剤としてのその使用
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
WO2001019792A1 (fr) 1999-09-17 2001-03-22 Genelabs Technologies, Inc. Molecules dimeres de liaison a l'adn liees de façon covalente
US6555693B2 (en) 2000-03-16 2003-04-29 Genesoft, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
KR20030011371A (ko) * 2000-06-27 2003-02-07 진랩스 테크놀러지스, 인크. 항세균, 항진균 또는 항암 활성을 갖는 신규 화합물
WO2002101007A2 (fr) 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc Composes benzamides anti-pathogenes
US6777425B2 (en) 2001-06-13 2004-08-17 Genesoft Pharmaceuticals, Inc. Isoquinoline compounds having antiinfective activity

Also Published As

Publication number Publication date
ATE509911T1 (de) 2011-06-15
JP2005519064A (ja) 2005-06-30
CA2470515A1 (fr) 2003-07-24
US7700765B2 (en) 2010-04-20
KR20040078651A (ko) 2004-09-10
CA2470515C (fr) 2011-06-07
KR100966520B1 (ko) 2010-06-29
EP1467969A2 (fr) 2004-10-20
GB0130868D0 (en) 2002-02-06
US20070117760A1 (en) 2007-05-24
JP2010174023A (ja) 2010-08-12
ES2395273T3 (es) 2013-02-11
JP4624675B2 (ja) 2011-02-02
WO2003059881A3 (fr) 2003-11-27
WO2003059881A2 (fr) 2003-07-24
EP1467969B1 (fr) 2011-05-18

Similar Documents

Publication Publication Date Title
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
HK1053473A1 (en) Inhibitors of alpha-l beta-2 mediated cell adhesion.
IL158485A0 (en) Spiropyrazole compounds
WO2007048065A3 (fr) Pyrimidinones en tant que modulateurs de caseine kinase ii (ck2)
WO2003047520A3 (fr) Inhibiteurs de facteur xa a aminomethyle substitue
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
AU2003250471A1 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
WO2001012202A3 (fr) Utilisation d'agents chimiques chelatants comme agents de neutralisation du blocage neuromusculaire provoque par des medicaments
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
WO2004092100A8 (fr) Derives d'indene utilises en tant qu'agents pharmaceutiques
AU2002356319A1 (en) Dna minor groove binding compounds
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
EP1671948A4 (fr) Compose de cinnamoyle et utilisation de ce compose
EP1671961A4 (fr) Compose cinnamoyle et utilisation associee
AU7399801A (en) Hydantoin derivatives with affinity for somatostatin receptors
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
CA2455298A1 (fr) Composes polycycliques condenses
WO2004048381A3 (fr) Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques
EP1310490A4 (fr) Antagoniste de gpr14
HK1049999A1 (en) Imidazole derivatives.
ATE282608T1 (de) Chinoxalindionen
AU2002361117A1 (en) 5-membered cyclic compounds
EP1118615A4 (fr) Nouveaux sels d'un compose de pyridopyrazine et cristaux desdits sels
WO2004093796A3 (fr) Derives lactame et procedes d'utilisation correspondants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase